If you cannot read this message, click here.
     DDNews Top 5 Cancer Stories
       JANUARY 2015
From our Cancer Research News exclusive:
A trio of culprits for triple negative breast cancer
By Kelsey Kaustinen, DDNews Senior Editor
The STP axis (consisting of the SCYL1, TEX14 and PLK1 proteins) is found to degrade REST, a tumor suppressor protein

From DDNews Online:
Mersana Therapeutics and Takeda expand antibody-drug conjugate partnership
By Lloyd Dunlap, DDNews Managing Editor
Companies to create novel Fleximer antibody-drug conjugate drug candidates to include additional oncology-relevant targets

From our January 2015 issue:
Two partners, three initiatives, five years
By Kelsey Kaustinen, DDNews Senior Editor
& Jeffrey Bouley, DDNews Chief Editor

Evotec and Sanofi forge three-part deal to improve innovation in drug discovery and preclinical development

From DDNews Online:
Evotec and Ohio State University collaborate on novel cancer therapy
By Lloyd Dunlap, DDNews Managing Editor
Collaboration leverages the breadth and experience of Evotec's drug discovery infrastructure to explore the use of a novel approach, discovered at Ohio State, for targeting mutant KRas

From our January 2015 issue:
Alion taps MPI for companion diagnostic
By Zack Anchors, DDNews Contributing Editor
Diagnostic would identify patients likely to respond to undisclosed ion channel inhibitor cancer treatment
Facebook Facebook
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600 | Fax: 440-331-7563
©2015 Old River Publications LLC. All Rights Reserved.
Web site designed and managed by Offenberger & White, Inc..
If you no longer wish to receive DDNews mailings, please unsubscribe here.